Elliott Richelson, MD: The Clinical Relevance of Antidepressant Interaction With Neurotransmitter Transporters and Receptors

Name: Elliott Richelson, MD: The Clinical Relevance of Antidepressant Interaction With Neurotransmitter Transporters and Receptors
SKU: 3067
Availability: InStock

$30.00

Want a discount? Become a member by purchasing Psychopharmacology Bulletin Subscription - Individual!

Categories: Psychopharmacology Bulletin, VOL 36 No. 4 Articles Tags: acetylcholine, dopamine, elliott-richelson, histamine, norepinephrine, serotonin

Description

Elliott Richelson, MD: The Clinical Relevance of Antidepressant Interaction With Neurotransmitter Transporters and Receptors

Description

Elliott Richelson, MD

GENERAL PSYCHOPHARMACOLOGY

The Clinical Relevance of Antidepressant Interaction With Neurotransmitter Transporters and Receptors

Elliott Richelson, MD

Coping With Somatic Comorbidities: Striving for Complete Recovery

VOL 3 No. 3 Full Issue – March 2001

Tyler M. McLeod, BS: Nitric Oxide, Stress, and Depression

Vicki L. Ellingrod, PharmD, BCPP: 5-HT2A Receptor Promoter Polymorphism, -1438G/A and Negative Symptom Response to Olanzapine in Schizophrenia

Elliott Richelson, MD: The Clinical Relevance of Antidepressant Interaction With Neurotransmitter Transporters and Receptors

Description

Elliott Richelson, MD

GENERAL PSYCHOPHARMACOLOGY

The Clinical Relevance of Antidepressant Interaction With Neurotransmitter Transporters and Receptors

Elliott Richelson, MD

Related products

Coping With Somatic Comorbidities: Striving for Complete Recovery

VOL 3 No. 3 Full Issue – March 2001

Tyler M. McLeod, BS: Nitric Oxide, Stress, and Depression

Vicki L. Ellingrod, PharmD, BCPP: 5-HT2A Receptor Promoter Polymorphism, -1438G/A and Negative Symptom Response to Olanzapine in Schizophrenia